Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis

INTRODUCTION: Trichilemmal carcinoma (TC) is a rare neoplasm of skin appendages. It was first described in 1968 as tricoleptocarcinoma, and has an incidence of 0.05% in patients subjected to histopathological examination after excision of cutaneous lesions. TC has an indolent clinical course ; howev...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Pedro Salomão Piccinini [verfasserIn] Francisco Carlos Santos Neto [verfasserIn] Gibran Busatto Chedid [verfasserIn] Jorge Hoyos [verfasserIn] Milton Paulo de Oliveira [verfasserIn] Carlos Oscar Uebel [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch ; Portugiesisch

Erschienen:	2016

Schlagwörter:	scalp oncology skin neoplasms carcinoma of skin appendages neoplasms of adnexal and skin appendages prognosis

Übergeordnetes Werk:	In: Revista Brasileira de Cirurgia Plástica - Sociedade Brasileira de Cirurgia Plástica, 2022, 31(2016), 01, Seite 101-104
Übergeordnetes Werk:	volume:31 ; year:2016 ; number:01 ; pages:101-104

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc Journal toc

DOI / URN:	10.5935/2177-1235.2016RBCP0015

Katalog-ID:	DOAJ096939710

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ096939710
003	DE-627
005	20240414083202.0
007	cr uuu---uuuuu
008	240413s2016 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.5935/2177-1235.2016RBCP0015 \|2 doi
035			\|a (DE-627)DOAJ096939710
035			\|a (DE-599)DOAJ23dafa4b13e044eebc5d5eee7c1d9bb1
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng \|a por
050		0	\|a RD1-811
100	0		\|a Pedro Salomão Piccinini \|e verfasserin \|4 aut
245	1	0	\|a Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis
264		1	\|c 2016
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a INTRODUCTION: Trichilemmal carcinoma (TC) is a rare neoplasm of skin appendages. It was first described in 1968 as tricoleptocarcinoma, and has an incidence of 0.05% in patients subjected to histopathological examination after excision of cutaneous lesions. TC has an indolent clinical course ; however, reports in the literature put in doubt this indolent behavior. OBJECTIVES: To provide an update on the management and prognosis of TC. METHODS:A search of the PubMed and SciELO databases by using with the MeSH terms "trichilemmal carcinoma", "tricholemmal carcinoma", "adnexal skin tumor", and "carcinoma triquilemal" was performed. RESULTS: Owing to the rarity of TC, most studies were case reports, which essentially corroborate the indolent nature of the disease. Surgical excision is the recommended treatment, and is associated with a low risk of recurrence and low morbidity and mortality. CONCLUSION: The behavior of the lesion and the procedure of treatment of TC are based on isolated cases or in a small series of cases. Because of its low prevalence, a multicenter collaboration of a greater number of cases can help define the best treatment recommendations, pathophysiology, and prognosis. Surgical excision remains the gold standard of treatment, and is associated with a low risk of recurrence.
650		4	\|a scalp
650		4	\|a oncology
650		4	\|a skin neoplasms
650		4	\|a carcinoma of skin appendages
650		4	\|a neoplasms of adnexal and skin appendages
650		4	\|a prognosis
653		0	\|a Surgery
700	0		\|a Francisco Carlos Santos Neto \|e verfasserin \|4 aut
700	0		\|a Gibran Busatto Chedid \|e verfasserin \|4 aut
700	0		\|a Jorge Hoyos \|e verfasserin \|4 aut
700	0		\|a Milton Paulo de Oliveira \|e verfasserin \|4 aut
700	0		\|a Carlos Oscar Uebel \|e verfasserin \|4 aut
773	0	8	\|i In \|t Revista Brasileira de Cirurgia Plástica \|d Sociedade Brasileira de Cirurgia Plástica, 2022 \|g 31(2016), 01, Seite 101-104 \|w (DE-627)1814168567 \|w (DE-600)3130895-8 \|x 21771235 \|7 nnns
773	1	8	\|g volume:31 \|g year:2016 \|g number:01 \|g pages:101-104
856	4	0	\|u https://doi.org/10.5935/2177-1235.2016RBCP0015 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/23dafa4b13e044eebc5d5eee7c1d9bb1 \|z kostenfrei
856	4	0	\|u http://www.rbcp.org.br/export-pdf/1718/en_v31n1a15.pdf \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1983-5175 \|y Journal toc \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2177-1235 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 31 \|j 2016 \|e 01 \|h 101-104

Indexfelder

author_variant	p s p psp f c s n fcsn g b c gbc j h jh m p d o mpdo c o u cou
matchkey_str	article:21771235:2016----::rciemlacnmaucmotmrpaentmn
hierarchy_sort_str	2016
callnumber-subject-code	RD
publishDate	2016
allfields	10.5935/2177-1235.2016RBCP0015 doi (DE-627)DOAJ096939710 (DE-599)DOAJ23dafa4b13e044eebc5d5eee7c1d9bb1 DE-627 ger DE-627 rakwb eng por RD1-811 Pedro Salomão Piccinini verfasserin aut Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier INTRODUCTION: Trichilemmal carcinoma (TC) is a rare neoplasm of skin appendages. It was first described in 1968 as tricoleptocarcinoma, and has an incidence of 0.05% in patients subjected to histopathological examination after excision of cutaneous lesions. TC has an indolent clinical course ; however, reports in the literature put in doubt this indolent behavior. OBJECTIVES: To provide an update on the management and prognosis of TC. METHODS:A search of the PubMed and SciELO databases by using with the MeSH terms "trichilemmal carcinoma", "tricholemmal carcinoma", "adnexal skin tumor", and "carcinoma triquilemal" was performed. RESULTS: Owing to the rarity of TC, most studies were case reports, which essentially corroborate the indolent nature of the disease. Surgical excision is the recommended treatment, and is associated with a low risk of recurrence and low morbidity and mortality. CONCLUSION: The behavior of the lesion and the procedure of treatment of TC are based on isolated cases or in a small series of cases. Because of its low prevalence, a multicenter collaboration of a greater number of cases can help define the best treatment recommendations, pathophysiology, and prognosis. Surgical excision remains the gold standard of treatment, and is associated with a low risk of recurrence. scalp oncology skin neoplasms carcinoma of skin appendages neoplasms of adnexal and skin appendages prognosis Surgery Francisco Carlos Santos Neto verfasserin aut Gibran Busatto Chedid verfasserin aut Jorge Hoyos verfasserin aut Milton Paulo de Oliveira verfasserin aut Carlos Oscar Uebel verfasserin aut In Revista Brasileira de Cirurgia Plástica Sociedade Brasileira de Cirurgia Plástica, 2022 31(2016), 01, Seite 101-104 (DE-627)1814168567 (DE-600)3130895-8 21771235 nnns volume:31 year:2016 number:01 pages:101-104 https://doi.org/10.5935/2177-1235.2016RBCP0015 kostenfrei https://doaj.org/article/23dafa4b13e044eebc5d5eee7c1d9bb1 kostenfrei http://www.rbcp.org.br/export-pdf/1718/en_v31n1a15.pdf kostenfrei https://doaj.org/toc/1983-5175 Journal toc kostenfrei https://doaj.org/toc/2177-1235 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 31 2016 01 101-104
spelling	10.5935/2177-1235.2016RBCP0015 doi (DE-627)DOAJ096939710 (DE-599)DOAJ23dafa4b13e044eebc5d5eee7c1d9bb1 DE-627 ger DE-627 rakwb eng por RD1-811 Pedro Salomão Piccinini verfasserin aut Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier INTRODUCTION: Trichilemmal carcinoma (TC) is a rare neoplasm of skin appendages. It was first described in 1968 as tricoleptocarcinoma, and has an incidence of 0.05% in patients subjected to histopathological examination after excision of cutaneous lesions. TC has an indolent clinical course ; however, reports in the literature put in doubt this indolent behavior. OBJECTIVES: To provide an update on the management and prognosis of TC. METHODS:A search of the PubMed and SciELO databases by using with the MeSH terms "trichilemmal carcinoma", "tricholemmal carcinoma", "adnexal skin tumor", and "carcinoma triquilemal" was performed. RESULTS: Owing to the rarity of TC, most studies were case reports, which essentially corroborate the indolent nature of the disease. Surgical excision is the recommended treatment, and is associated with a low risk of recurrence and low morbidity and mortality. CONCLUSION: The behavior of the lesion and the procedure of treatment of TC are based on isolated cases or in a small series of cases. Because of its low prevalence, a multicenter collaboration of a greater number of cases can help define the best treatment recommendations, pathophysiology, and prognosis. Surgical excision remains the gold standard of treatment, and is associated with a low risk of recurrence. scalp oncology skin neoplasms carcinoma of skin appendages neoplasms of adnexal and skin appendages prognosis Surgery Francisco Carlos Santos Neto verfasserin aut Gibran Busatto Chedid verfasserin aut Jorge Hoyos verfasserin aut Milton Paulo de Oliveira verfasserin aut Carlos Oscar Uebel verfasserin aut In Revista Brasileira de Cirurgia Plástica Sociedade Brasileira de Cirurgia Plástica, 2022 31(2016), 01, Seite 101-104 (DE-627)1814168567 (DE-600)3130895-8 21771235 nnns volume:31 year:2016 number:01 pages:101-104 https://doi.org/10.5935/2177-1235.2016RBCP0015 kostenfrei https://doaj.org/article/23dafa4b13e044eebc5d5eee7c1d9bb1 kostenfrei http://www.rbcp.org.br/export-pdf/1718/en_v31n1a15.pdf kostenfrei https://doaj.org/toc/1983-5175 Journal toc kostenfrei https://doaj.org/toc/2177-1235 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 31 2016 01 101-104
allfields_unstemmed	10.5935/2177-1235.2016RBCP0015 doi (DE-627)DOAJ096939710 (DE-599)DOAJ23dafa4b13e044eebc5d5eee7c1d9bb1 DE-627 ger DE-627 rakwb eng por RD1-811 Pedro Salomão Piccinini verfasserin aut Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier INTRODUCTION: Trichilemmal carcinoma (TC) is a rare neoplasm of skin appendages. It was first described in 1968 as tricoleptocarcinoma, and has an incidence of 0.05% in patients subjected to histopathological examination after excision of cutaneous lesions. TC has an indolent clinical course ; however, reports in the literature put in doubt this indolent behavior. OBJECTIVES: To provide an update on the management and prognosis of TC. METHODS:A search of the PubMed and SciELO databases by using with the MeSH terms "trichilemmal carcinoma", "tricholemmal carcinoma", "adnexal skin tumor", and "carcinoma triquilemal" was performed. RESULTS: Owing to the rarity of TC, most studies were case reports, which essentially corroborate the indolent nature of the disease. Surgical excision is the recommended treatment, and is associated with a low risk of recurrence and low morbidity and mortality. CONCLUSION: The behavior of the lesion and the procedure of treatment of TC are based on isolated cases or in a small series of cases. Because of its low prevalence, a multicenter collaboration of a greater number of cases can help define the best treatment recommendations, pathophysiology, and prognosis. Surgical excision remains the gold standard of treatment, and is associated with a low risk of recurrence. scalp oncology skin neoplasms carcinoma of skin appendages neoplasms of adnexal and skin appendages prognosis Surgery Francisco Carlos Santos Neto verfasserin aut Gibran Busatto Chedid verfasserin aut Jorge Hoyos verfasserin aut Milton Paulo de Oliveira verfasserin aut Carlos Oscar Uebel verfasserin aut In Revista Brasileira de Cirurgia Plástica Sociedade Brasileira de Cirurgia Plástica, 2022 31(2016), 01, Seite 101-104 (DE-627)1814168567 (DE-600)3130895-8 21771235 nnns volume:31 year:2016 number:01 pages:101-104 https://doi.org/10.5935/2177-1235.2016RBCP0015 kostenfrei https://doaj.org/article/23dafa4b13e044eebc5d5eee7c1d9bb1 kostenfrei http://www.rbcp.org.br/export-pdf/1718/en_v31n1a15.pdf kostenfrei https://doaj.org/toc/1983-5175 Journal toc kostenfrei https://doaj.org/toc/2177-1235 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 31 2016 01 101-104
allfieldsGer	10.5935/2177-1235.2016RBCP0015 doi (DE-627)DOAJ096939710 (DE-599)DOAJ23dafa4b13e044eebc5d5eee7c1d9bb1 DE-627 ger DE-627 rakwb eng por RD1-811 Pedro Salomão Piccinini verfasserin aut Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier INTRODUCTION: Trichilemmal carcinoma (TC) is a rare neoplasm of skin appendages. It was first described in 1968 as tricoleptocarcinoma, and has an incidence of 0.05% in patients subjected to histopathological examination after excision of cutaneous lesions. TC has an indolent clinical course ; however, reports in the literature put in doubt this indolent behavior. OBJECTIVES: To provide an update on the management and prognosis of TC. METHODS:A search of the PubMed and SciELO databases by using with the MeSH terms "trichilemmal carcinoma", "tricholemmal carcinoma", "adnexal skin tumor", and "carcinoma triquilemal" was performed. RESULTS: Owing to the rarity of TC, most studies were case reports, which essentially corroborate the indolent nature of the disease. Surgical excision is the recommended treatment, and is associated with a low risk of recurrence and low morbidity and mortality. CONCLUSION: The behavior of the lesion and the procedure of treatment of TC are based on isolated cases or in a small series of cases. Because of its low prevalence, a multicenter collaboration of a greater number of cases can help define the best treatment recommendations, pathophysiology, and prognosis. Surgical excision remains the gold standard of treatment, and is associated with a low risk of recurrence. scalp oncology skin neoplasms carcinoma of skin appendages neoplasms of adnexal and skin appendages prognosis Surgery Francisco Carlos Santos Neto verfasserin aut Gibran Busatto Chedid verfasserin aut Jorge Hoyos verfasserin aut Milton Paulo de Oliveira verfasserin aut Carlos Oscar Uebel verfasserin aut In Revista Brasileira de Cirurgia Plástica Sociedade Brasileira de Cirurgia Plástica, 2022 31(2016), 01, Seite 101-104 (DE-627)1814168567 (DE-600)3130895-8 21771235 nnns volume:31 year:2016 number:01 pages:101-104 https://doi.org/10.5935/2177-1235.2016RBCP0015 kostenfrei https://doaj.org/article/23dafa4b13e044eebc5d5eee7c1d9bb1 kostenfrei http://www.rbcp.org.br/export-pdf/1718/en_v31n1a15.pdf kostenfrei https://doaj.org/toc/1983-5175 Journal toc kostenfrei https://doaj.org/toc/2177-1235 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 31 2016 01 101-104
allfieldsSound	10.5935/2177-1235.2016RBCP0015 doi (DE-627)DOAJ096939710 (DE-599)DOAJ23dafa4b13e044eebc5d5eee7c1d9bb1 DE-627 ger DE-627 rakwb eng por RD1-811 Pedro Salomão Piccinini verfasserin aut Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier INTRODUCTION: Trichilemmal carcinoma (TC) is a rare neoplasm of skin appendages. It was first described in 1968 as tricoleptocarcinoma, and has an incidence of 0.05% in patients subjected to histopathological examination after excision of cutaneous lesions. TC has an indolent clinical course ; however, reports in the literature put in doubt this indolent behavior. OBJECTIVES: To provide an update on the management and prognosis of TC. METHODS:A search of the PubMed and SciELO databases by using with the MeSH terms "trichilemmal carcinoma", "tricholemmal carcinoma", "adnexal skin tumor", and "carcinoma triquilemal" was performed. RESULTS: Owing to the rarity of TC, most studies were case reports, which essentially corroborate the indolent nature of the disease. Surgical excision is the recommended treatment, and is associated with a low risk of recurrence and low morbidity and mortality. CONCLUSION: The behavior of the lesion and the procedure of treatment of TC are based on isolated cases or in a small series of cases. Because of its low prevalence, a multicenter collaboration of a greater number of cases can help define the best treatment recommendations, pathophysiology, and prognosis. Surgical excision remains the gold standard of treatment, and is associated with a low risk of recurrence. scalp oncology skin neoplasms carcinoma of skin appendages neoplasms of adnexal and skin appendages prognosis Surgery Francisco Carlos Santos Neto verfasserin aut Gibran Busatto Chedid verfasserin aut Jorge Hoyos verfasserin aut Milton Paulo de Oliveira verfasserin aut Carlos Oscar Uebel verfasserin aut In Revista Brasileira de Cirurgia Plástica Sociedade Brasileira de Cirurgia Plástica, 2022 31(2016), 01, Seite 101-104 (DE-627)1814168567 (DE-600)3130895-8 21771235 nnns volume:31 year:2016 number:01 pages:101-104 https://doi.org/10.5935/2177-1235.2016RBCP0015 kostenfrei https://doaj.org/article/23dafa4b13e044eebc5d5eee7c1d9bb1 kostenfrei http://www.rbcp.org.br/export-pdf/1718/en_v31n1a15.pdf kostenfrei https://doaj.org/toc/1983-5175 Journal toc kostenfrei https://doaj.org/toc/2177-1235 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 31 2016 01 101-104
language	English Portuguese
source	In Revista Brasileira de Cirurgia Plástica 31(2016), 01, Seite 101-104 volume:31 year:2016 number:01 pages:101-104
sourceStr	In Revista Brasileira de Cirurgia Plástica 31(2016), 01, Seite 101-104 volume:31 year:2016 number:01 pages:101-104
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	scalp oncology skin neoplasms carcinoma of skin appendages neoplasms of adnexal and skin appendages prognosis Surgery
isfreeaccess_bool	true
container_title	Revista Brasileira de Cirurgia Plástica
authorswithroles_txt_mv	Pedro Salomão Piccinini @@aut@@ Francisco Carlos Santos Neto @@aut@@ Gibran Busatto Chedid @@aut@@ Jorge Hoyos @@aut@@ Milton Paulo de Oliveira @@aut@@ Carlos Oscar Uebel @@aut@@
publishDateDaySort_date	2016-01-01T00:00:00Z
hierarchy_top_id	1814168567
id	DOAJ096939710
language_de	englisch portugiesisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ096939710</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414083202.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2016 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.5935/2177-1235.2016RBCP0015</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ096939710</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ23dafa4b13e044eebc5d5eee7c1d9bb1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">por</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RD1-811</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Pedro Salomão Piccinini</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">INTRODUCTION: Trichilemmal carcinoma (TC) is a rare neoplasm of skin appendages. It was first described in 1968 as tricoleptocarcinoma, and has an incidence of 0.05% in patients subjected to histopathological examination after excision of cutaneous lesions. TC has an indolent clinical course ; however, reports in the literature put in doubt this indolent behavior. OBJECTIVES: To provide an update on the management and prognosis of TC. METHODS:A search of the PubMed and SciELO databases by using with the MeSH terms "trichilemmal carcinoma", "tricholemmal carcinoma", "adnexal skin tumor", and "carcinoma triquilemal" was performed. RESULTS: Owing to the rarity of TC, most studies were case reports, which essentially corroborate the indolent nature of the disease. Surgical excision is the recommended treatment, and is associated with a low risk of recurrence and low morbidity and mortality. CONCLUSION: The behavior of the lesion and the procedure of treatment of TC are based on isolated cases or in a small series of cases. Because of its low prevalence, a multicenter collaboration of a greater number of cases can help define the best treatment recommendations, pathophysiology, and prognosis. Surgical excision remains the gold standard of treatment, and is associated with a low risk of recurrence.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">scalp</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">skin neoplasms</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">carcinoma of skin appendages</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">neoplasms of adnexal and skin appendages</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">prognosis</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Surgery</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Francisco Carlos Santos Neto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Gibran Busatto Chedid</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jorge Hoyos</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Milton Paulo de Oliveira</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Carlos Oscar Uebel</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Revista Brasileira de Cirurgia Plástica</subfield><subfield code="d">Sociedade Brasileira de Cirurgia Plástica, 2022</subfield><subfield code="g">31(2016), 01, Seite 101-104</subfield><subfield code="w">(DE-627)1814168567</subfield><subfield code="w">(DE-600)3130895-8</subfield><subfield code="x">21771235</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:31</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:01</subfield><subfield code="g">pages:101-104</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.5935/2177-1235.2016RBCP0015</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/23dafa4b13e044eebc5d5eee7c1d9bb1</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.rbcp.org.br/export-pdf/1718/en_v31n1a15.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1983-5175</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2177-1235</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">31</subfield><subfield code="j">2016</subfield><subfield code="e">01</subfield><subfield code="h">101-104</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Pedro Salomão Piccinini
spellingShingle	Pedro Salomão Piccinini misc RD1-811 misc scalp misc oncology misc skin neoplasms misc carcinoma of skin appendages misc neoplasms of adnexal and skin appendages misc prognosis misc Surgery Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis
authorStr	Pedro Salomão Piccinini
ppnlink_with_tag_str_mv	@@773@@(DE-627)1814168567
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RD1-811
illustrated	Not Illustrated
issn	21771235
topic_title	RD1-811 Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis scalp oncology skin neoplasms carcinoma of skin appendages neoplasms of adnexal and skin appendages prognosis
topic	misc RD1-811 misc scalp misc oncology misc skin neoplasms misc carcinoma of skin appendages misc neoplasms of adnexal and skin appendages misc prognosis misc Surgery
topic_unstemmed	misc RD1-811 misc scalp misc oncology misc skin neoplasms misc carcinoma of skin appendages misc neoplasms of adnexal and skin appendages misc prognosis misc Surgery
topic_browse	misc RD1-811 misc scalp misc oncology misc skin neoplasms misc carcinoma of skin appendages misc neoplasms of adnexal and skin appendages misc prognosis misc Surgery
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Revista Brasileira de Cirurgia Plástica
hierarchy_parent_id	1814168567
hierarchy_top_title	Revista Brasileira de Cirurgia Plástica
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)1814168567 (DE-600)3130895-8
title	Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis
ctrlnum	(DE-627)DOAJ096939710 (DE-599)DOAJ23dafa4b13e044eebc5d5eee7c1d9bb1
title_full	Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis
author_sort	Pedro Salomão Piccinini
journal	Revista Brasileira de Cirurgia Plástica
journalStr	Revista Brasileira de Cirurgia Plástica
callnumber-first-code	R
lang_code	eng por
isOA_bool	true
recordtype	marc
publishDateSort	2016
contenttype_str_mv	txt
container_start_page	101
author_browse	Pedro Salomão Piccinini Francisco Carlos Santos Neto Gibran Busatto Chedid Jorge Hoyos Milton Paulo de Oliveira Carlos Oscar Uebel
container_volume	31
class	RD1-811
format_se	Elektronische Aufsätze
author-letter	Pedro Salomão Piccinini
doi_str_mv	10.5935/2177-1235.2016RBCP0015
author2-role	verfasserin
title_sort	trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis
callnumber	RD1-811
title_auth	Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis
abstract	INTRODUCTION: Trichilemmal carcinoma (TC) is a rare neoplasm of skin appendages. It was first described in 1968 as tricoleptocarcinoma, and has an incidence of 0.05% in patients subjected to histopathological examination after excision of cutaneous lesions. TC has an indolent clinical course ; however, reports in the literature put in doubt this indolent behavior. OBJECTIVES: To provide an update on the management and prognosis of TC. METHODS:A search of the PubMed and SciELO databases by using with the MeSH terms "trichilemmal carcinoma", "tricholemmal carcinoma", "adnexal skin tumor", and "carcinoma triquilemal" was performed. RESULTS: Owing to the rarity of TC, most studies were case reports, which essentially corroborate the indolent nature of the disease. Surgical excision is the recommended treatment, and is associated with a low risk of recurrence and low morbidity and mortality. CONCLUSION: The behavior of the lesion and the procedure of treatment of TC are based on isolated cases or in a small series of cases. Because of its low prevalence, a multicenter collaboration of a greater number of cases can help define the best treatment recommendations, pathophysiology, and prognosis. Surgical excision remains the gold standard of treatment, and is associated with a low risk of recurrence.
abstractGer	INTRODUCTION: Trichilemmal carcinoma (TC) is a rare neoplasm of skin appendages. It was first described in 1968 as tricoleptocarcinoma, and has an incidence of 0.05% in patients subjected to histopathological examination after excision of cutaneous lesions. TC has an indolent clinical course ; however, reports in the literature put in doubt this indolent behavior. OBJECTIVES: To provide an update on the management and prognosis of TC. METHODS:A search of the PubMed and SciELO databases by using with the MeSH terms "trichilemmal carcinoma", "tricholemmal carcinoma", "adnexal skin tumor", and "carcinoma triquilemal" was performed. RESULTS: Owing to the rarity of TC, most studies were case reports, which essentially corroborate the indolent nature of the disease. Surgical excision is the recommended treatment, and is associated with a low risk of recurrence and low morbidity and mortality. CONCLUSION: The behavior of the lesion and the procedure of treatment of TC are based on isolated cases or in a small series of cases. Because of its low prevalence, a multicenter collaboration of a greater number of cases can help define the best treatment recommendations, pathophysiology, and prognosis. Surgical excision remains the gold standard of treatment, and is associated with a low risk of recurrence.
abstract_unstemmed	INTRODUCTION: Trichilemmal carcinoma (TC) is a rare neoplasm of skin appendages. It was first described in 1968 as tricoleptocarcinoma, and has an incidence of 0.05% in patients subjected to histopathological examination after excision of cutaneous lesions. TC has an indolent clinical course ; however, reports in the literature put in doubt this indolent behavior. OBJECTIVES: To provide an update on the management and prognosis of TC. METHODS:A search of the PubMed and SciELO databases by using with the MeSH terms "trichilemmal carcinoma", "tricholemmal carcinoma", "adnexal skin tumor", and "carcinoma triquilemal" was performed. RESULTS: Owing to the rarity of TC, most studies were case reports, which essentially corroborate the indolent nature of the disease. Surgical excision is the recommended treatment, and is associated with a low risk of recurrence and low morbidity and mortality. CONCLUSION: The behavior of the lesion and the procedure of treatment of TC are based on isolated cases or in a small series of cases. Because of its low prevalence, a multicenter collaboration of a greater number of cases can help define the best treatment recommendations, pathophysiology, and prognosis. Surgical excision remains the gold standard of treatment, and is associated with a low risk of recurrence.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	01
title_short	Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis
url	https://doi.org/10.5935/2177-1235.2016RBCP0015 https://doaj.org/article/23dafa4b13e044eebc5d5eee7c1d9bb1 http://www.rbcp.org.br/export-pdf/1718/en_v31n1a15.pdf https://doaj.org/toc/1983-5175 https://doaj.org/toc/2177-1235
remote_bool	true
author2	Francisco Carlos Santos Neto Gibran Busatto Chedid Jorge Hoyos Milton Paulo de Oliveira Carlos Oscar Uebel
author2Str	Francisco Carlos Santos Neto Gibran Busatto Chedid Jorge Hoyos Milton Paulo de Oliveira Carlos Oscar Uebel
ppnlink	1814168567
callnumber-subject	RD - Surgery
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.5935/2177-1235.2016RBCP0015
callnumber-a	RD1-811
up_date	2024-07-03T23:03:02.118Z
_version_	1803600823187406848
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ096939710</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414083202.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2016 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.5935/2177-1235.2016RBCP0015</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ096939710</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ23dafa4b13e044eebc5d5eee7c1d9bb1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">por</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RD1-811</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Pedro Salomão Piccinini</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">INTRODUCTION: Trichilemmal carcinoma (TC) is a rare neoplasm of skin appendages. It was first described in 1968 as tricoleptocarcinoma, and has an incidence of 0.05% in patients subjected to histopathological examination after excision of cutaneous lesions. TC has an indolent clinical course ; however, reports in the literature put in doubt this indolent behavior. OBJECTIVES: To provide an update on the management and prognosis of TC. METHODS:A search of the PubMed and SciELO databases by using with the MeSH terms "trichilemmal carcinoma", "tricholemmal carcinoma", "adnexal skin tumor", and "carcinoma triquilemal" was performed. RESULTS: Owing to the rarity of TC, most studies were case reports, which essentially corroborate the indolent nature of the disease. Surgical excision is the recommended treatment, and is associated with a low risk of recurrence and low morbidity and mortality. CONCLUSION: The behavior of the lesion and the procedure of treatment of TC are based on isolated cases or in a small series of cases. Because of its low prevalence, a multicenter collaboration of a greater number of cases can help define the best treatment recommendations, pathophysiology, and prognosis. Surgical excision remains the gold standard of treatment, and is associated with a low risk of recurrence.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">scalp</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">skin neoplasms</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">carcinoma of skin appendages</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">neoplasms of adnexal and skin appendages</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">prognosis</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Surgery</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Francisco Carlos Santos Neto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Gibran Busatto Chedid</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jorge Hoyos</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Milton Paulo de Oliveira</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Carlos Oscar Uebel</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Revista Brasileira de Cirurgia Plástica</subfield><subfield code="d">Sociedade Brasileira de Cirurgia Plástica, 2022</subfield><subfield code="g">31(2016), 01, Seite 101-104</subfield><subfield code="w">(DE-627)1814168567</subfield><subfield code="w">(DE-600)3130895-8</subfield><subfield code="x">21771235</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:31</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:01</subfield><subfield code="g">pages:101-104</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.5935/2177-1235.2016RBCP0015</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/23dafa4b13e044eebc5d5eee7c1d9bb1</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.rbcp.org.br/export-pdf/1718/en_v31n1a15.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1983-5175</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2177-1235</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">31</subfield><subfield code="j">2016</subfield><subfield code="e">01</subfield><subfield code="h">101-104</subfield></datafield></record></collection>
score	7.3996134

Nicht das Richtige dabei?

Schreiben Sie uns!

Trichilemmal carcinoma, an uncommon tumor: update on its management and prognosis

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?